Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(13%)
Results Posted
43%(3 trials)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_2
1
13%
Ph phase_4
4
50%
Ph phase_1
2
25%

Phase Distribution

2

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 4Post-market surveillance
4(50.0%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(7)

Detailed Status

Completed7
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 21 (12.5%)
Phase 44 (50.0%)
N/A1 (12.5%)

Trials by Status

completed788%
recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
recruitingphase_2

Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer

NCT06437574
completednot_applicable

To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

NCT01420328
completedphase_4

Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.

NCT00988364
completedphase_1

Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)

NCT00652431
completedphase_1

Vytorin in the Treatment of Alopecia Areata

NCT01520077
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06437574Phase 2

Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer

Recruiting
NCT01420328Not Applicable

To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

Completed
NCT00988364Phase 4

Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.

Completed
NCT00652431Phase 1

Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)

Completed
NCT01520077Phase 1

Vytorin in the Treatment of Alopecia Areata

Completed
NCT01660945Phase 4

Vascular and Metabolic Effects of Vytorin

Completed
NCT01666067Phase 4

Vascular and Metabolic Effects of Vytorin vs Simvastatin

Completed
NCT00762164Phase 4

Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8